12th International Congress of TDM & Clinical Toxicology
October 2 - 6, 2011
Stuttgart Germany
View photos from the Congress!

Foster and promote education and research in therapeutic drug monitoring and clinical toxicology;

Improve the standards of practice and clinical interpretation of drug and toxic substance analyses and facilitate the delivery of interpretation through clinical pharmacokinetics and toxicokinetics for enhanced patient care;

Encourage cooperation with and among members of all professions concerned with TDM and clinical toxicology;

Encourage the effective application of therapeutic drug monitoring to optimize clinical drug use and maximize the clinical and economic benefits;

Encourage progress in clinical toxicology as a diagnostic tool and therapeutic aid for therapeutic drug overdoses, drug abuse, and exposure to environmental toxicants.

Application form (PDF)

Therapeutic Drug Monitoring is the official journal of IATDMCT

IATDMCT members have free on-line access to the journal Therapeutic Drug Monitoring.

YS Committee

	YS Chair Denise Anne McKeown, London, UK (dmckeown@bioanalytics.co.uk)

	YS Vice Chair Dr. Markus R Meyer, Homburg, Germany (markus.meyer@uks.eu)

	YS Web Editor Dr Sarah Wille, Brussels, Belgium (sarah.wille@just.fgov.be)

	YS Committee Member Dr Frank Saint-Marcoux, Limoges, France (mailto:franck.saint-marcoux@unilim.fr

	YS Committee Member Jennifer Button, London, UK (jenny.button@lgcstandards.com)

	YS Committee Member Dr Reinier Van Hest, The Netherlands (r.m.vanhest@amc.uva.nl)

	YS Committee Member Dr Ryuji Kato, Osaka, Japan (rkato@gly.oups.ac.jp)

Members Only